Incidence and risk factors of drug‐induced liver injury

X Li, J Tang, Y Mao - Liver International, 2022 - Wiley Online Library
The epidemiology and aetiology of drug‐induced liver injury (DILI) vary across different
countries and populations. Overall, DILI is rare in the general population but has become …

Drug-induced hepatotoxicity: a review

A Pandit, T Sachdeva, P Bafna - Journal of Applied Pharmaceutical …, 2012 - japsonline.com
Liver is the principle organ for maintaining the body's internal environment. There is
currently no way to reimburse for the absence of liver function. Its major influence is on the …

Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study

Data Collection on Adverse Events of Anti … - Archives of internal …, 2006 - jamanetwork.com
Background An increasing proportion of deaths among human immunodeficiency virus (HIV)–
infected persons with access to combination antiretroviral therapy (cART) are due to …

Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines

H Devarbhavi, G Aithal, S Treeprasertsuk… - Hepatology …, 2021 - Springer
Idiosyncratic drug-induced liver injury mimics acute and chronic liver disease. It is under
recognized and underrecognised because of the lack of pathognomonic diagnostic …

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort

D Konopnicki, A Mocroft, S De Wit, F Antunes… - Aids, 2005 - journals.lww.com
Background: Whether hepatitis B (HBV) coinfection affects outcome in HIV-1-infected
patients remains unclear. Objective: To assess the prevalence of HBV (assessed as HBsAg) …

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label …

F van Leth, P Phanuphak, K Ruxrungtham, E Baraldi… - The Lancet, 2004 - thelancet.com
Summary Background The 2NN Study was a randomised comparison of the non-nucleoside
reverse-transcriptase inhibitors (NNRTI) nevirapine and efavirenz. Methods In this …

[BOOK][B] Guidelines for the screening, care and treatment of persons with hepatitis C infection

World Health Organization - 2014 - apps.who.int
Appendices published as WHO/HIV/2014.22, WHO/HIV/2014.24, WHO/HIV/2014.28,
WHO/HIV/2014.29, WHO/HIV/2014.30, WHO/HIV/2014.33, WHO/HIV/2014.34 …

Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment

EL Corbett, B Marston, GJ Churchyard, KM De Cock - The Lancet, 2006 - thelancet.com
Rapid scale-up of antiretroviral treatment programmes is happening in Africa, driven by
international advocacy and policy directives and supported by unprecedented donor funding …

Risk factors for idiosyncratic drug-induced liver injury

N Chalasani, E Björnsson - Gastroenterology, 2010 - Elsevier
Idiosyncratic drug-induced liver injury (DILI) is a rare disorder that is not related directly to
dosage and little is known about individuals who are at increased risk. There are no suitable …

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis

HH Thein, Q Yi, GJ Dore, MD Krahn - Aids, 2008 - journals.lww.com
Objectives: To estimate stage-specific transition probabilities in individuals coinfected with
HIV and hepatitis C virus (HCV), to examine the effect of covariates on these rates, and to …